You Searched For: sec-Butyl+butyrate
5,042 results were found
BRLSPIMMUNOSURF 170518 Imm SurfaceMatters
/m-no.vwr.com/no_NO/images/BRLSPIMMUNOSURF_170518_Imm_SurfaceMatters.pdf
Thermo Scientific Immunoassay Plate Guide • Passive binding of biomacromolecules • Covalent coupling of smaller biomolecules • Capture of affinity-tagged biomolecules The right surface for your assay 2 Well configuration Advanced immunoassay surfa...
BRLSPIMMUNOSURF 170518 Imm SurfaceMatters
/m-ch.vwr.com/fr_CH/images/BRLSPIMMUNOSURF_170518_Imm_SurfaceMatters.pdf
Thermo Scientific Immunoassay Plate Guide • Passive binding of biomacromolecules • Covalent coupling of smaller biomolecules • Capture of affinity-tagged biomolecules The right surface for your assay 2 Well configuration Advanced immunoassay surfa...
BRLSPIMMUNOSURF 170518 Imm SurfaceMatters
/m-fr.vwr.com/fr_FR/images/BRLSPIMMUNOSURF_170518_Imm_SurfaceMatters.pdf
Thermo Scientific Immunoassay Plate Guide • Passive binding of biomacromolecules • Covalent coupling of smaller biomolecules • Capture of affinity-tagged biomolecules The right surface for your assay 2 Well configuration Advanced immunoassay surfa...
BRLSPIMMUNOSURF 170518 Imm SurfaceMatters
/m-ie.vwr.com/en_IE/images/BRLSPIMMUNOSURF_170518_Imm_SurfaceMatters.pdf
Thermo Scientific Immunoassay Plate Guide • Passive binding of biomacromolecules • Covalent coupling of smaller biomolecules • Capture of affinity-tagged biomolecules The right surface for your assay 2 Well configuration Advanced immunoassay surfa...
~~A18L14A UHP SEC analysis of biosimilars~~
/it.vwr.com/it_IT/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-se.vwr.com/sv_SE/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-dk.vwr.com/da_DK/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
~~A18L14A UHP SEC analysis of biosimilars~~
/m-in.vwr.com/en_IN/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-ch.vwr.com/de_CH/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
~~A18L14A UHP SEC analysis of biosimilars~~
/m-cn.vwr.com/zh_CN/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-pt.vwr.com/pt_PT/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-ie.vwr.com/en_IE/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-kr.vwr.com/ko_KR/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-hu.vwr.com/hu_HU/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-ch.vwr.com/it_CH/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
289 - 304 of 5,042